Clinical Trial Update: Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Lactobacillus rhamnosus GG and its interaction with human gut and skin microbiota and humoral immunity, in relation to sever…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lactobacillus rhamnosus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Turku University Hospital | Conditions: Gut Microbiota, Skin Microbiota | Phase 4 | Status: COMPLETED